These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11263516

  • 1. Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997.
    Abe C, Hirano K, Wada M, Aoyagi T.
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):46-52. PubMed ID: 11263516
    [Abstract] [Full Text] [Related]

  • 2. [Anti-tuberculosis drug resistance in Japan and in the world].
    Abe C.
    Kekkaku; 2001 Nov; 76(11):699-706. PubMed ID: 11766361
    [Abstract] [Full Text] [Related]

  • 3. [A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
    Hirano K, Wada M, Abe C, Aoyagi T.
    Kekkaku; 2001 Jun; 76(6):461-71. PubMed ID: 11494526
    [Abstract] [Full Text] [Related]

  • 4. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
    Cheong SV, Lao UL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 9. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G, Miörner H, Ahmed O, Hoffner SE.
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [Abstract] [Full Text] [Related]

  • 10. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A.
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.
    Migliori GB, Fattorini L, Vaccarino P, Besozzi G, Saltini C, Orefici G, Iona E, Matteelli A, Fiorentini F, Codecasa LR, Casali L, Cassone A, SMIRA (Italian Multicentre Study on Resistance to Anti-tuberculosis drugs) Study Group.
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):32-8. PubMed ID: 11931399
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of acquired MDR-TB and HIV co-infection.
    Deivanayagam CN, Rajasekaran S, Venkatesan R, Mahilmaran A, Ahmed PR, Annadurai S, Kumar S, Chandrasekar C, Ravichandran N, Pencillaiah R.
    Indian J Chest Dis Allied Sci; 2002 Jan; 44(4):237-42. PubMed ID: 12437236
    [Abstract] [Full Text] [Related]

  • 14. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G, González J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PR, Escaramís G, Ascaso C, García A, Jiménez de Anta MT.
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [Abstract] [Full Text] [Related]

  • 15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 16. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 Oct; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

  • 18. Anti-tuberculosis drug resistance in two clinics in Ecuador.
    Mertz BL, Douce RW, Brito N.
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):115-7. PubMed ID: 10694088
    [Abstract] [Full Text] [Related]

  • 19. [A study on prevalence of resistance to antituberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory].
    Kazumi Y, Hirano K, Abe C, Mori T, Aoki M, Aoyagi T.
    Kekkaku; 1996 Mar; 71(3):267-76. PubMed ID: 8901229
    [Abstract] [Full Text] [Related]

  • 20. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia.
    Kordy FN, Al-Thawadi S, Alrajhi AA.
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):1007-11. PubMed ID: 15305485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.